The core targets (ESR1, FASN, mTOR, HIF-1α, VEGFA, and GSK-3β) of SYTZD against NAFLD were imported into the DAVID database for KEGG analysis. This evidence concerns the gene GSK3B and metabolic dysfunction-associated steatotic liver disease.